Sell Deepak Nitrite; target of Rs 1300: Motilal Oswal
Moneycontrol • 1 day ago
Key Investment Pillars
- Phenolics segment growth: DN's Phenolics segment drove the strong 2QFY27 performance, with a 72% YoY revenue growth and 3.6x YoY EBIT growth, due to favorable realizations amid import disruptions and healthy domestic demand.
- Advanced Intermediates (AI) segment recovery: The AI segment showed a 38% YoY revenue growth, driven by steady demand in established products, improved realizations, and initial contributions from new products, with a target of 14-15% EBIT margin in FY28.
- New project ramp-ups: DN has commissioned new plants, including chlorination and specialty chemicals, and is ramping up production of Methyl Isobutyl Ketone (MIBK) and Methyl Isobutyl Carbinol (MIBC), with optimal utilization targeted in FY28.
- Polycarbonate complex: DN is building India's first integrated polycarbonate complex, with a 165ktpa resin plant expected to be completed in FY29, and full optimization by FY31.
Thesis Validation Checklist
- Sustained Phenolics profitability: Monitor if Phenolics segment margins remain healthy in 3QFY27, driven by favorable realizations and cost optimization.
- AI segment margin expansion: Track if AI segment EBIT margin reaches the targeted 14-15% in FY28, driven by new product contributions and cost pass-through.
- New project utilization: Monitor the utilization levels of newly commissioned plants, including MIBK and MIBC, and the progress of the polycarbonate complex.
- Import normalization: Watch for signs of import normalization, which could impact DN's competitiveness and profitability.
- Competition and market share: Monitor the competitive landscape and DN's market share in the Phenolics and AI segments.